Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Mark Ragosa Sells 1,123 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) CFO Mark Ragosa sold 1,123 shares of the firm’s stock in a...
Fructose May Drive Cancer Growth: Animal Study
By George Citroner A sweetener known as fructose may give cancer tumors a boost, and researchers advise that avoiding it...
MeridianLink, Inc. (NYSE:MLNK) Major Shareholder Timothy Nguyen Sells 27,500 Shares
MeridianLink, Inc. (NYSE:MLNK – Get Free Report) major shareholder Timothy Nguyen sold 27,500 shares of the company’s stock in a...
Insider Selling: Hagerty, Inc. (NYSE:HGTY) Director Sells 9,322 Shares of Stock
Hagerty, Inc. (NYSE:HGTY – Get Free Report) Director Robert I. Kauffman sold 9,322 shares of the firm’s stock in a...
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Purchases $403,200.00 in Stock
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L acquired 42,000 shares of the business’s stock...
Zumiez (NASDAQ:ZUMZ) Issues Q4 2024 Earnings Guidance
Zumiez (NASDAQ:ZUMZ – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The...